Use of β-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: Are we on target?

American Heart Journal

Volumn 158, Issue 3, 2009, Pages 378-385

  Herman, Michael ^a,c   Donovan, Jennifer ^a,c   Tran, Maichi ^a,b,c   McKenna, Brigid ^a,b   Gore, Joel M ^a,b   Goldberg, Robert J ^a,b   Tighe, Dennis A ^a,b  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFECT; FEMALE; HEART RATE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGED; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; METOPROLOL; MIDDLE AGED;

EID: 68949108706     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.06.023     Document Type: Article

References (39)

1. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304 (1981) 801-807
2. Beta-Blocker Heart Attack Study Group. A randomized trial of propranolol in patients with acute myocardial infarction: mortality results. JAMA 247 (1982) 1707-1714
3. Hansteen V., Moinichen E., Lorentsen E., et al. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian Multicentre Trial. BMJ 284 (1982) 155-160
4. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
5. Gottlieb S.S., McCarter R.J., and Vogel R.A. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med 339 (1998) 489-497
6. Teo K.K., Yusuf S., and Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 270 (1993) 1589-1595
7. Freemantle N., Cleland J., Young P., et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
8. Hjalmarson A., Elmfeldt D., Herlitz J., et al. Effect on mortality of metoprolol in acute myocardial infarction: a double-blind randomized trial. Lancet 2 (1981) 823-827
9. Norris R.M., Brown M.A., Clarke E.D., et al. Prevention of ventricular fibrillation during acute myocardial infarction by intravenous propranolol. Lancet 2 (1984) 883-886
10. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group. Eur Heart J 6 (1985) 199-226
11. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction. ISIS-1. Lancet 2 (1986) 57-66
12. Yusuf S., Peto R., Lewis J., et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 27 (1985) 335-371
13. Roberts R., Rogers W.J., Mueller H.S., et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) II-B study. Circulation 83 (1991) 422-437
14. Pfisterer M., Cox J.L., Granger C.B., et al. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 32 (1998) 634-640
15. Chen Z., Pan H., Peto R., et al. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
16. Kjekshus J.K. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 57 (1986) 43F-49F
17. Goldman L., Sia S.T., Cook E.F., et al. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after myocardial infarction. N Engl J Med 319 (1988) 152-157
18. Cucherat M., Boissel J.P., and Leizorovicz A. Persistent reduction of mortality for five years after one year of acebutolol treatment initiated during acute myocardial infarction. The APSI Investigators. Acebutolol et Prevention Secondaire de l'Infarctus. Am J Cardiol 79 (1997) 587-589
19. Antman E.M., Hand M., Armstrong P.W., et al. 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction). Circulation 117 (2008) 296-329
20. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 Guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction). J Am Coll Cardiol 50 (2007) el-e157
21. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 28 (2007) 1598-1660
22. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 (2003) 28-66
23. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44 (2004) e1-e211
24. Gundersen T., Grottum P., Pedersen T., et al. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 58 (1986) 20-24
25. Hjalmarson A., Gilpin E.A., Kjekshus J., et al. Influence of heart rate on mortality after myocardial infarction. Am J Cardiol 65 (1990) 547-553
26. Thygesen K., Alpert J.S., and White H.D. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
27. Acute Myocardial Infarction Core Measure Set. Available at:. http://www.jointcommission.org/PerformanceMeasurement/PerformanceMeasure ment/Acute+Myocardial+Infarction+Core+Measure+Set.htm
28. Lange R., Kloner R.A., and Braunwald E. First ultra-short-acting beta-adrenergic blocking agent: its effect on size and segmental wall dynamics of reperfused myocardial infarcts in dogs. Am J Cardiol 51 (1983) 1759-1767
29. Grines C.L., Booth D.C., Nissen S.E., et al. Acute effects of parenteral beta-blockade on regional ventricular function of infarct and noninfarct zones after reperfusion therapy in humans. J Am Coll Cardiol 17 (1991) 1382-1387
30. Murray D.P., Murray R.G., Rafiqi E., et al. Beta-adrenergic blockade in acute myocardial infarction: a hemodynamic and radionuclide study. Eur Heart J 8 (1987) 845-854
31. Van der Werf F., Janssens L., Brzostek T., et al. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy. J Am Coll Cardiol 22 (1993) 407-416
32. Viskin S., Kitzis I., Lev E., et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. J Am Coll Cardiol 25 (1995) 1327-1332
33. Krumholz H.M., Radford M.J., Wang Y., et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280 (1998) 623-629
34. Soumerai S.B., McLaughlin T.J., Spiegelman D., et al. Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA 277 (1997) 115-121
35. Butler J., Arbogast P.G., BeLue R., et al. Outpatient adherence to beta-blocker therapy after acute myocardial infarction. J Am Coll Cardiol 40 (2002) 1589-1595
36. Chen J., Radford M.J., Wang Y., et al. Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?. Arch Intern Med 160 (2000) 947-952
37. Chen J., Marciniak T.A., Radford M.J., et al. Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients: results from the National Cooperative Cardiovascular Project. J Am Coll Cardiol 34 (1999) 1388-1394
38. Chen J., Radford M.J., Wang Y., et al. Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma. J Am Coll Cardiol 37 (2001) 1950-1956
39. Chobanian A.V., Bakris G.L., Black H.R., et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42 (2003) 1206-1252